{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:03:24Z","timestamp":1793109804626,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI129709-03S1"],"award-info":[{"award-number":["AI129709-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200-2016-91773"],"award-info":[{"award-number":["200-2016-91773"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX005507-0."],"award-info":[{"award-number":["BX005507-0."]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Data suggest that antibody responses following COVID-19 vaccines are a correlate of protection. Some studies, including the clinical trials of COVID-19 mRNA vaccines, did not stratify and evaluate whether antibody responses to COVID-19 vaccines differed between the sexes or with aging. This gap in research is particularly relevant for older populations such as nursing home residents (NHR). We hypothesized that sex differences in vaccine-induced antibody responses may intersect with age and be diminished among older adults residing in nursing homes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed serum samples from 638 NHRs collected serially after the primary two-dose series and three subsequent booster doses of mRNA SARS-CoV-2 vaccinations. We analyzed anti-Spike IgG and neutralizing antibody titers to the Wuhan and Omicron BA.4\/5 variant strains. Mixed-effects models predicting log-transformed titers were estimated to compare responses across vaccine doses, focusing on sex-differential responses. For detected post-dose sex differences, additional sample times were analyzed to assess the duration of the difference.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Following the primary series, female NHRs with a prior history of SARS-CoV-2 infection had significantly higher Wuhan anti-Spike antibodies and neutralizing antibody titers than male NHRs with differences persisting up to nine months post-vaccination. Subsequent monovalent booster doses and a bivalent booster dose eliminated this disparity. We did not detect any differential response to the Omicron BA.4\/5 variant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The blunting of sex differences in antibody response observed following the primary series by the 1st booster dose underscores the importance of booster vaccination in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-025-02990-0","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T22:25:19Z","timestamp":1741386319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["COVID-19 booster doses reduce sex disparities in antibody responses among nursing home residents"],"prefix":"10.1007","volume":"37","author":[{"given":"Oladayo A.","family":"Oyebanji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Sundheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Ragavapuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakeena","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Mujahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Abul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro B.","family":"Balazs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabra L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Canaday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"issue":"29\u201330","key":"2990_CR1","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","volume":"26","author":"IF Cook","year":"2008","unstructured":"Cook IF (2008) Sexual dimorphism of humoral immunity with human vaccines. Vaccine 26(29\u201330):3551\u20133555. https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.054","journal-title":"Vaccine"},{"issue":"2","key":"2990_CR2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4415\/ANN_16_02_11","volume":"52","author":"A Ruggieri","year":"2016","unstructured":"Ruggieri A, Anticoli S, D\u2019Ambrosio A et al (2016) The influence of sex and gender on immunity, infection and vaccination. Annali dell\u2019Istituto Superiore Di Sanita 52(2):198\u2013204. https:\/\/doi.org\/10.4415\/ANN_16_02_11","journal-title":"Annali dell\u2019Istituto Superiore Di Sanita"},{"issue":"2","key":"2990_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-018-0726-5","volume":"41","author":"S Fischinger","year":"2019","unstructured":"Fischinger S, Boudreau CM, Butler AL et al (2019) Sex differences in vaccine-induced humoral immunity. Semin Immunopathol 41(2):239\u2013249. https:\/\/doi.org\/10.1007\/s00281-018-0726-5","journal-title":"Semin Immunopathol"},{"key":"2990_CR4","unstructured":"Offord C (2023) Sex differences in immune responses to viral infection. Accessed 2nd November https:\/\/www.the-scientist.com\/features\/sex-differences-in-immune-responses-to-viral-infection-68466"},{"key":"2990_CR5","doi-asserted-by":"publisher","unstructured":"Ciarambino T, Barbagelata E, Corbi G et al (2021) Gender differences in vaccine therapy: where are we in COVID-19 pandemic? Monaldi archives for chest disease. 91(4). https:\/\/doi.org\/10.4081\/monaldi.2021.1669","DOI":"10.4081\/monaldi.2021.1669"},{"key":"2990_CR6","doi-asserted-by":"publisher","first-page":"106700","DOI":"10.1016\/j.cct.2022.106700","volume":"115","author":"A Jensen","year":"2022","unstructured":"Jensen A, Stromme M, Moyassari S, Chadha AS, Tartaglia MC, Szoeke C, Ferretti MT (2022) COVID-19 vaccines: considering sex differences in efficacy and safety. Contemp Clin Trials 115:106700. https:\/\/doi.org\/10.1016\/j.cct.2022.106700","journal-title":"Contemp Clin Trials"},{"key":"2990_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13293-021-00410-2","volume":"12","author":"S Qi","year":"2021","unstructured":"Qi S, Ngwa C, Scheihing M (2021) Sex differences in the immune response to acute COVID-19 respiratory tract infection. Biol Sex Differ 12:66. https:\/\/doi.org\/10.1186\/s13293-021-00410-2","journal-title":"Biol Sex Differ"},{"issue":"1","key":"2990_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.idc.2022.11.002","volume":"37","author":"OA Oyebanji","year":"2023","unstructured":"Oyebanji OA, Mylonakis E, Canaday DH (2023) Vaccines for the prevention of coronavirus disease 2019 in older adults. Infect Disease Clin 37(1):27\u201345. https:\/\/doi.org\/10.1016\/j.idc.2022.11.002","journal-title":"Infect Disease Clin"},{"key":"2990_CR9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3389\/fimmu.2020.02147","volume":"11","author":"N Gadi","year":"2020","unstructured":"Gadi N, Wu SC, Spihlman AP, Moulton VR (2020) What\u2019s sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses. Front Immunol 11:2147. https:\/\/doi.org\/10.3389\/fimmu.2020.02147","journal-title":"Front Immunol"},{"key":"2990_CR10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fpubh.2020.00418","volume":"8","author":"J Kopel","year":"2020","unstructured":"Kopel J, Perisetti A, Roghani A, Aziz M, Gajendran M, Goyal H (2020) Racial and gender-based differences in COVID-19. Front Public Health 8:418. https:\/\/doi.org\/10.3389\/fpubh.2020.00418","journal-title":"Front Public Health"},{"key":"2990_CR11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nri2394","volume":"8","author":"E Fish","year":"2008","unstructured":"Fish E (2008) The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8:737\u2013744. https:\/\/doi.org\/10.1038\/nri2394","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2990_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/cancers14040909","volume":"14","author":"AT Harding","year":"2022","unstructured":"Harding AT, Heaton NS (2022) The impact of estrogens and their receptors on immunity and inflammation during infection. Cancers (Basel) 14(4):909 Published 2022 Feb 12. https:\/\/doi.org\/10.3390\/cancers14040909","journal-title":"Cancers (Basel)"},{"key":"2990_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1152\/physiol.00035.2015","volume":"30","author":"AL Fink","year":"2015","unstructured":"Fink AL, Klein SL (2015) Sex and gender impact immune responses to vaccines among the elderly. Physiology 30:408\u2013416. https:\/\/doi.org\/10.1152\/physiol.00035.2015","journal-title":"Physiology"},{"key":"2990_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-35139-6_9","volume-title":"Sex and gender differences in infection and treatments for infectious diseases. Current topics in microbiology and immunology","author":"LA St. Clair","year":"2023","unstructured":"St. Clair LA, Chaulagain S, Klein SL, Benn CS, Flanagan KL (2023) Sex-differential and non-specific effects of vaccines over the life course. In: Klein SL, Roberts CW (eds) Sex and gender differences in infection and treatments for infectious diseases. Current Topics in Microbiology and Immunology, vol 441. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-35139-6_9"},{"key":"2990_CR15","doi-asserted-by":"publisher","unstructured":"Ciarambino T, Para O, Giordano M (2021) Immune system and COVID-19 by sex differences and age. Women\u2019s Health 17. https:\/\/doi.org\/10.1177\/17455065211022262","DOI":"10.1177\/17455065211022262"},{"key":"2990_CR16","doi-asserted-by":"publisher","first-page":"786586","DOI":"10.3389\/fimmu.2022.786586","volume":"13","author":"J Bai","year":"2022","unstructured":"Bai J, Chiba A, Murayama G, Kuga T, Tamura N, Miyake S (2022) Sex, age, and ethnic background shape adaptive immune responses induced by the SARS-CoV-2 mRNA vaccine. Front Immunol 13:786586. https:\/\/doi.org\/10.3389\/fimmu.2022.786586","journal-title":"Front Immunol"},{"key":"2990_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully EP, Haverfield J, Ursin RL et al (2020) Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol 20:442\u2013447. https:\/\/doi.org\/10.1038\/s41577-020-0348-8","journal-title":"Nat Rev Immunol"},{"key":"2990_CR18","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi T, Ellingson MK, Wong P et al (2020) Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588:315\u2013320. https:\/\/doi.org\/10.1038\/s41586-020-2700-3","journal-title":"Nature"},{"key":"2990_CR19","doi-asserted-by":"publisher","unstructured":"Carson L, Smith E, Didion H, Aung et al (2024) Longitudinal analysis of nursing home residents\u2019 T cell responses after SARS-CoV-2 mRNA vaccinations shows influence of biological sex and SARS-CoV-2 infection history. J Infect Dis jiae234. https:\/\/doi.org\/10.1093\/infdis\/jiae234","DOI":"10.1093\/infdis\/jiae234"},{"issue":"11","key":"2990_CR20","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1093\/cid\/ciab447","volume":"73","author":"DH Canaday","year":"2021","unstructured":"Canaday DH, Carias L, Oyebanji OA et al (2021) Reduced BNT162b2 messenger RNA vaccine response in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)\u2013naive nursing home residents. Clin Infect Dis 73(11):2112\u20132115. https:\/\/doi.org\/10.1093\/cid\/ciab447","journal-title":"Clin Infect Dis"},{"issue":"22","key":"2990_CR21","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1016\/j.vaccine.2023.04.034","volume":"41","author":"C Nugent","year":"2023","unstructured":"Nugent C, Abul Y, White EM et al (2023) Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers. Vaccine 41(22):3403\u20133409. https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.034","journal-title":"Vaccine"},{"issue":"4","key":"2990_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.15585\/mmwr.mm7204a4","volume":"72","author":"DH Canaday","year":"2023","unstructured":"Canaday DH, Oyebanji OA, White EM et al (2023) SARS-CoV-2 antibody responses to the ancestral SARS-CoV-2 strain and Omicron BA. 1 and BA. 4\/BA. 5 variants in nursing home residents after receipt of bivalent COVID-19 vaccine\u2014Ohio and Rhode Island, September\u2013November 2022. Morb Mortal Wkly Rep 72(4):100. https:\/\/doi.org\/10.15585\/mmwr.mm7204a4","journal-title":"Morb Mortal Wkly Rep"},{"key":"2990_CR23","doi-asserted-by":"publisher","unstructured":"Oyebanji OA, Abul Y, Wilson BM et al (2023 Aug) Neutralization and binding antibody response to second bivalent COVID-19 vaccination in nursing home residents. J Am Geriatr Soc 17. https:\/\/doi.org\/10.1111\/jgs.18557","DOI":"10.1111\/jgs.18557"},{"key":"2990_CR24","doi-asserted-by":"publisher","unstructured":"Oyebanji OA, Sundheimer N, Ragavapuram V et al (2024) Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers. GeroScience https:\/\/doi.org\/10.1007\/s11357-024-01215-y","DOI":"10.1007\/s11357-024-01215-y"},{"issue":"2","key":"2990_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.cell.2020.12.015","volume":"184","author":"WF Garcia-Beltran","year":"2021","unstructured":"Garcia-Beltran WF, Lam EC, Astudillo MG et al (2021) COVID-19-neutralizing antibodies predict disease severity and survival. Cell 184(2):476\u2013488e11. https:\/\/doi.org\/10.1016\/j.cell.2020.12.015","journal-title":"Cell"},{"issue":"13","key":"2990_CR26","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.vaccine.2011.01.071","volume":"29","author":"KL Flanagan","year":"2011","unstructured":"Flanagan KL, Klein SL, Skakkebaek NE et al (2011) Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine 29(13):2349\u20132354. https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.071","journal-title":"Vaccine"},{"key":"2990_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","volume":"33","author":"KL Flanagan","year":"2017","unstructured":"Flanagan KL, Fink AL, Plebanski M, Klein SL (2017) Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol 33:577\u2013599. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060718","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2990_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/all.15652","volume":"78","author":"D Brigger","year":"2023","unstructured":"Brigger D, Guntern P, Jonsdottir HR, Pennington LF, Weber B, Taddeo A, Zimmer G, Leborgne NGF, Benarafa C, Jardetzky TS, Eggel A (2023) Sex-specific differences in immune response to SARS-CoV-2 vaccination vanish with age. Allergy 78:1683\u20131686. https:\/\/doi.org\/10.1111\/all.15652","journal-title":"Allergy"},{"key":"2990_CR29","doi-asserted-by":"publisher","unstructured":"Shapiro JR, et al (2022 Aug 15) Association of frailty, age, and biological sex with severe acute respiratory syndrome coronavirus 2 messenger RNA Vaccine-Induced immunity in older adults. Clin Infect Dis 775(Suppl 1):S61\u2013S71. https:\/\/doi.org\/10.1093\/cid\/ciac397","DOI":"10.1093\/cid\/ciac397"},{"issue":"5","key":"2990_CR30","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11739-023-03283-y","volume":"18","author":"C Trevisan","year":"2023","unstructured":"Trevisan C, Raparelli V, Malara A et al (2023) Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study. Intern Emerg Med 18(5):1337\u20131347. https:\/\/doi.org\/10.1007\/s11739-023-03283-y","journal-title":"Intern Emerg Med"},{"key":"2990_CR31","doi-asserted-by":"publisher","unstructured":"Ludivine Grzelak Aur\u00e9lie, Velay Y, Madec et al (2021 Sep 15) Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2. J Infect Dis 224(6):983\u2013988. https:\/\/doi.org\/10.1093\/infdis\/jiab127","DOI":"10.1093\/infdis\/jiab127"},{"key":"2990_CR32","doi-asserted-by":"publisher","first-page":"836642","DOI":"10.3389\/fragi.2022.836642","volume":"3","author":"JR Shapiro","year":"2022","unstructured":"Shapiro JR, Morgan R, Leng SX, Klein SL (2022) Roadmap for sex-responsive influenza and COVID-19 vaccine research in older adults. Front Aging 3:836642. https:\/\/doi.org\/10.3389\/fragi.2022.836642","journal-title":"Front Aging"},{"key":"2990_CR33","doi-asserted-by":"publisher","unstructured":"Wang C, Lashua LP, Carter CE, Johnson SK, Wang M, Ross TM, Ghedin E, Zhang B, Forst CV (2022) Sex disparities in influenza: A multiscale network analysis. Iscience 25(5). https:\/\/doi.org\/10.1016\/j.isci.2022.104192","DOI":"10.1016\/j.isci.2022.104192"},{"key":"2990_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","volume":"4","author":"T Potluri","year":"2019","unstructured":"Potluri T, Fink AL, Sylvia KE et al (2019) Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females. Npj Vaccines 4:29. https:\/\/doi.org\/10.1038\/s41541-019-0124-6","journal-title":"Npj Vaccines"},{"issue":"7","key":"2990_CR35","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/infdis\/jiab592","volume":"225","author":"MA Brockman","year":"2022","unstructured":"Brockman MA, Mwimanzi F, Lapointe HR et al (2022) Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults. J Infect Dis 225(7):1129\u20131140. https:\/\/doi.org\/10.1093\/infdis\/jiab592","journal-title":"J Infect Dis"},{"issue":"2","key":"2990_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/vaccines11020463","volume":"11","author":"LV Renna","year":"2023","unstructured":"Renna LV, Bertani F, Podio A et al (2023) Impact of BNT162b2 booster dose on SARS-CoV-2 anti-trimeric spike antibody dynamics in a large cohort of Italian health care workers. Vaccines 11(2):463. https:\/\/doi.org\/10.3390\/vaccines11020463","journal-title":"Vaccines"},{"key":"2990_CR37","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/joim.13601","volume":"293","author":"JE Ebinger","year":"2023","unstructured":"Ebinger JE, Joung SY, Wang M et al (2023) Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. J Intern Med 293:520\u2013523. https:\/\/doi.org\/10.1111\/joim.13601","journal-title":"J Intern Med"},{"issue":"1","key":"2990_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41541-021-00412-6","volume":"6","author":"JR Shapiro","year":"2021","unstructured":"Shapiro JR, Li H, Morgan R et al (2021) Sex-specific effects of aging on humoral immune responses to repeated influenza vaccination in older adults. NPJ Vaccines 6(1):147. https:\/\/doi.org\/10.1038\/s41541-021-00412-6. PMID: 34887436; PMCID: PMC8660902","journal-title":"NPJ Vaccines"},{"issue":"5","key":"2990_CR39","doi-asserted-by":"publisher","first-page":"ofae222","DOI":"10.1093\/ofid\/ofae222","volume":"11","author":"F Tadount","year":"2024","unstructured":"Tadount F, Kiely M, Assi A et al (2024) Sex differences in the immunogenicity and efficacy of seasonal influenza vaccines: A Meta-analysis of randomized controlled trials. Open Forum Infect Dis 11(5):ofae222. https:\/\/doi.org\/10.1093\/ofid\/ofae222. PMID: 38737434; PMCID: PMC11088355","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"2990_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/ppar\/prad027","volume":"33","author":"S Yanicke","year":"2023","unstructured":"Yanicke S, Ucar D (2023) Sex differences in immune system aging and responsiveness to vaccination. Public Policy Aging Rep 33(4):125\u2013127. https:\/\/doi.org\/10.1093\/ppar\/prad027. PMID: 38155932; PMCID: PMC10751359","journal-title":"Public Policy Aging Rep"},{"key":"2990_CR41","doi-asserted-by":"publisher","first-page":"e001268","DOI":"10.1136\/bmjresp-2022-001268","volume":"9","author":"ZB Harboe","year":"2022","unstructured":"Harboe ZB, Hamm SR, P\u00e9rez- Al\u00f3s L et al (2022) Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID- 19 vaccination in patients with chronic pulmonary diseases. BMJ Open Resp Res 9:e001268. https:\/\/doi.org\/10.1136\/bmjresp-2022-001268","journal-title":"BMJ Open Resp Res"},{"issue":"5","key":"2990_CR42","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/fampra\/cmaa040","volume":"37","author":"JM Groeneveld","year":"2020","unstructured":"Groeneveld JM, Ballering AV, van Boven K et al (2020) Sex differences in incidence of respiratory symptoms and management by general practitioners. Fam Pract 37(5):631\u2013636. https:\/\/doi.org\/10.1093\/fampra\/cmaa040","journal-title":"Fam Pract"},{"key":"2990_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13293-020-00330-7","volume":"11","author":"A Pradhan","year":"2020","unstructured":"Pradhan A, Olsson PE (2020) Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biol Sex Differ 11:53. https:\/\/doi.org\/10.1186\/s13293-020-00330-7","journal-title":"Biol Sex Differ"},{"issue":"4","key":"2990_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/jamainternmed.2020.7968","volume":"181","author":"OA Panagiotou","year":"2021","unstructured":"Panagiotou OA, Kosar CM, White EM et al (2021) Risk factors associated with all-cause 30-Day mortality in nursing home residents with COVID-19. JAMA Intern Med 181(4):439\u2013448. https:\/\/doi.org\/10.1001\/jamainternmed.2020.7968","journal-title":"JAMA Intern Med"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-02990-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-025-02990-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-025-02990-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T10:08:36Z","timestamp":1741428516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-025-02990-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1007\/s40520-025-02990-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.23.24315989","asserted-by":"object"}]},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Western-Copernicus Group Institutional Review Board (WCG IRB). All participating residents or their legally authorized representatives provided informed consent to be enrolled.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Stefan Gravenstein (S.G) and David H. Canaday (D.H.C) receive investigator-initiated grants to their universities from Pfizer to study pneumococcal vaccines and Sanofi Pasteur to study influenza vaccines. S.G. also consults for Astra Zeneca, GlaxoSmithKline, Janssen, Moderna, Novavax, Pfizer, Sanofi, Seqirus, and Vaxart and has received honoraria for speaking engagements from Astra Zeneca, Janssen, Moderna, Novavax, Pfizer, Sanofi, and Seqirus.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}